Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208524

BELVIQ XR (LORCASERIN HYDROCHLORIDE)
20MG
Marketing Status: Discontinued
Active Ingredient: LORCASERIN HYDROCHLORIDE
Proprietary Name: BELVIQ XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N208524
Product Number: 001
Approval Date: Jul 15, 2016
Applicant Holder Full Name: EISAI INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English